IKZF1/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma
| Published in: | Haematologica |
|---|---|
| Main Authors: | Santiago Barrio, Umair Munawar, Yuan Xiao Zhu, Nicola Giesen, Chang-Xin Shi, Matteo Da Viá, Ricardo Sanchez, Laura Bruins, Theresa Demler, Nicole Müller, Larissa Haertle, Andoni Garitano, Torsten Steinbrunn, Sophia Danhof, Isabel Cuenca, Clara Barrio-Garcia, Esteban Braggio, Andreas Rosenwald, Joaquin Martinez-Lopez, Leo Rasche, Marc S. Raab, A. Keith Stewart, Hermann Einsele, Thorsten Stühmer, K. Martin Kortüm |
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2020-05-01
|
| Online Access: | https://haematologica.org/article/view/9410 |
Similar Items
Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4<sup>CRBN</sup> Protein Degradation Axis
by: Seung-Joo Yang, et al.
Published: (2021-05-01)
by: Seung-Joo Yang, et al.
Published: (2021-05-01)
GCK inhibition enhances iberdomide antimyeloma effects by promoting IKZF1 degradation via a CRBN-independent mechanism
by: Shirong Li, et al.
Published: (2025-08-01)
by: Shirong Li, et al.
Published: (2025-08-01)
IMiD compounds affect CD34+ cell fate and maturation via CRBN-induced IKZF1 degradation
by: Shirong Li, et al.
Published: (2018-03-01)
by: Shirong Li, et al.
Published: (2018-03-01)
Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma
by: David Kegyes, et al.
Published: (2025-08-01)
by: David Kegyes, et al.
Published: (2025-08-01)
Unveiling the hidden interactome of CRBN molecular glues
by: Kheewoong Baek, et al.
Published: (2025-07-01)
by: Kheewoong Baek, et al.
Published: (2025-07-01)
Design, Synthesis, and Biological Evaluation of HDAC Degraders with CRBN E3 Ligase Ligands
by: Yingxin Lu, et al.
Published: (2021-11-01)
by: Yingxin Lu, et al.
Published: (2021-11-01)
The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma
by: Mohamed H. S. Awwad, et al.
Published: (2018-10-01)
by: Mohamed H. S. Awwad, et al.
Published: (2018-10-01)
RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS
by: Marcel Seibold, et al.
Published: (2019-10-01)
by: Marcel Seibold, et al.
Published: (2019-10-01)
Pathogenic role of the CRL4 ubiquitin ligase in human disease
by: Pengbo eZhou
Published: (2012-03-01)
by: Pengbo eZhou
Published: (2012-03-01)
Plasmodium falciparum contains functional SCF and CRL4 ubiquitin E3 ligases, and CRL4 is critical for cell division and membrane integrity.
by: Zeba Rizvi, et al.
Published: (2024-02-01)
by: Zeba Rizvi, et al.
Published: (2024-02-01)
Alterations of the IKZF1-IKZF2 tandem in immune cells of schizophrenia patients regulate associated phenotypes
by: Iván Ballasch, et al.
Published: (2024-12-01)
by: Iván Ballasch, et al.
Published: (2024-12-01)
The Relationship Between the Expression of CRBN in Peripheral Blood and the Severity and Prognosis of Adult Sepsis
by: Kuang Z, et al.
Published: (2023-11-01)
by: Kuang Z, et al.
Published: (2023-11-01)
Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myeloma
by: Larissa Haertle, et al.
Published: (2024-07-01)
by: Larissa Haertle, et al.
Published: (2024-07-01)
Molecular insights into degron recognition by CRL5ASB7 ubiquitin ligase
by: Mengyu Zhou, et al.
Published: (2024-07-01)
by: Mengyu Zhou, et al.
Published: (2024-07-01)
Efficient transient transfection of human multiple myeloma cells by electroporation--an appraisal.
by: Torsten Steinbrunn, et al.
Published: (2014-01-01)
by: Torsten Steinbrunn, et al.
Published: (2014-01-01)
Unraveling the Engagement of Kinases to CRBN Through a Shared Structural Motif to Optimize PROTACs Efficacy
by: Serena Rosignoli, et al.
Published: (2025-02-01)
by: Serena Rosignoli, et al.
Published: (2025-02-01)
CRBN modulates synuclein fibrillation via degradation of DNAJB1 in mouse model of Parkinson disease
by: Uroos Akber, et al.
Published: (2024-10-01)
by: Uroos Akber, et al.
Published: (2024-10-01)
CB1R AS A POTENTIAL THERAPEUTIC TARGET IN CRBN DEFICIENCY-ASSOCIATED MENTAL RETARDATION
by: Alba Hermoso-López, et al.
Published: (2023-10-01)
by: Alba Hermoso-López, et al.
Published: (2023-10-01)
Thalidomide Attenuates Mast Cell Activation by Upregulating SHP-1 Signaling and Interfering with the Action of CRBN
by: Hyeun-Wook Chang, et al.
Published: (2023-02-01)
by: Hyeun-Wook Chang, et al.
Published: (2023-02-01)
CUL4-DDB1-CRBN E3 Ubiquitin Ligase Regulates Proteostasis of ClC-2 Chloride Channels: Implication for Aldosteronism and Leukodystrophy
by: Ssu-Ju Fu, et al.
Published: (2020-05-01)
by: Ssu-Ju Fu, et al.
Published: (2020-05-01)
Functional characterization of Cullin-1-RING ubiquitin ligase (CRL1) complex in Leishmania infantum.
by: Camila Rolemberg Santana Travaglini Berti de Correia, et al.
Published: (2024-07-01)
by: Camila Rolemberg Santana Travaglini Berti de Correia, et al.
Published: (2024-07-01)
Biophysical and functional study of CRL5Ozz, a muscle specific ubiquitin ligase complex
by: Yvan Campos, et al.
Published: (2022-05-01)
by: Yvan Campos, et al.
Published: (2022-05-01)
In-cell proximity target validation methods for heterobifunctional molecules with CRBN- or VHL-binder using AirID
by: Kohdai Yamada, et al.
Published: (2025-08-01)
by: Kohdai Yamada, et al.
Published: (2025-08-01)
Comparative Genomics Identifies Putative Interspecies Mechanisms Underlying Crbn-Sall4-Linked Thalidomide Embryopathy
by: Thayne Woycinck Kowalski, et al.
Published: (2021-06-01)
by: Thayne Woycinck Kowalski, et al.
Published: (2021-06-01)
BCMA loss in the epoch of novel immunotherapy for multiple myeloma: from biology to clinical practice
by: Xiang Zhou, et al.
Published: (2022-10-01)
by: Xiang Zhou, et al.
Published: (2022-10-01)
CSN-CRL Complexes: New Regulators of Adipogenesis
by: Dawadschargal Dubiel, et al.
Published: (2025-03-01)
by: Dawadschargal Dubiel, et al.
Published: (2025-03-01)
Mechanism of Ψ-Pro/C-degron recognition by the CRL2FEM1B ubiquitin ligase
by: Xinyan Chen, et al.
Published: (2024-04-01)
by: Xinyan Chen, et al.
Published: (2024-04-01)
Study on Toughness Evaluation and Indentation Finite Element Simulation of the Ni/Cu Co-Doped CrBN Coatings
by: ZHOU Ming-ling, WANG Qian-zhi
Published: (2022-02-01)
by: ZHOU Ming-ling, WANG Qian-zhi
Published: (2022-02-01)
A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degrader
by: Monica C. Rodrigo-Brenni, et al.
Published: (2026-03-01)
by: Monica C. Rodrigo-Brenni, et al.
Published: (2026-03-01)
PB2391: FREQUENCY OF IKZF3 MUTATION IN WALDENSTRÖM’S MACROGLOBULINEMIA
by: Assia Taleb, et al.
Published: (2023-08-01)
by: Assia Taleb, et al.
Published: (2023-08-01)
Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia
by: Jasmijn D.E. de Rooij, et al.
Published: (2015-09-01)
by: Jasmijn D.E. de Rooij, et al.
Published: (2015-09-01)
The clinical impact of IKZF1 mutation in acute myeloid leukemia
by: Xiang Zhang, et al.
Published: (2023-03-01)
by: Xiang Zhang, et al.
Published: (2023-03-01)
P836: ANTIBODY-DRUG CONJUGATES AS POTENTIAL CAR-T CELL SPECIFIC OFF-SWITCH IN MULTIPLE MYELOMA
by: Anna Bielowski, et al.
Published: (2023-08-01)
by: Anna Bielowski, et al.
Published: (2023-08-01)
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells
by: Estefanía García-Guerrero, et al.
Published: (2022-09-01)
by: Estefanía García-Guerrero, et al.
Published: (2022-09-01)
Fundacja muzyczna ks. Jana Brodowskiego CRL (1675)
by: Czesław Grajewski, et al.
Published: (2024-06-01)
by: Czesław Grajewski, et al.
Published: (2024-06-01)
A CRlTICISM FOR THE ENVIRONMENTAL PROTECTION ORGANISATION IN TURKEY
by: Sultan BEKİROĞLU
Published: (2006-08-01)
by: Sultan BEKİROĞLU
Published: (2006-08-01)
NRBP1-Containing CRL2/CRL4A Regulates Amyloid β Production by Targeting BRI2 and BRI3 for Degradation
by: Takashi Yasukawa, et al.
Published: (2020-03-01)
by: Takashi Yasukawa, et al.
Published: (2020-03-01)
The small CRL4CSA ubiquitin ligase component DDA1 regulates transcription-coupled repair dynamics
by: Diana A. Llerena Schiffmacher, et al.
Published: (2024-07-01)
by: Diana A. Llerena Schiffmacher, et al.
Published: (2024-07-01)
The E3 Ubiquitin Ligase CRL5 Regulates Dentate Gyrus Morphogenesis, Adult Neurogenesis, and Animal Behavior
by: Raenier V. Reyes, et al.
Published: (2022-06-01)
by: Raenier V. Reyes, et al.
Published: (2022-06-01)
Differential substrate degradation by super-degron: EGFP in wild-type mouse cells, PD-1 requires CRBN humanization
by: Chie Naruse, et al.
Published: (2025-07-01)
by: Chie Naruse, et al.
Published: (2025-07-01)
Similar Items
-
Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4<sup>CRBN</sup> Protein Degradation Axis
by: Seung-Joo Yang, et al.
Published: (2021-05-01) -
GCK inhibition enhances iberdomide antimyeloma effects by promoting IKZF1 degradation via a CRBN-independent mechanism
by: Shirong Li, et al.
Published: (2025-08-01) -
IMiD compounds affect CD34+ cell fate and maturation via CRBN-induced IKZF1 degradation
by: Shirong Li, et al.
Published: (2018-03-01) -
Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma
by: David Kegyes, et al.
Published: (2025-08-01) -
Unveiling the hidden interactome of CRBN molecular glues
by: Kheewoong Baek, et al.
Published: (2025-07-01)
